Welcome to the e-CCO Library!

DOP007: Interleukin-10 inhibits human IFNγ and IL-17-producing T helper cells indirectly by controlling antigen-presenting cell function
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. Veenbergen*1, P. Li2, H. Raatgeep1, D. Lindenbergh-Kortleve1, L. de Ruiter1, M. van Leeuwen1, D. Winter3, Y. Simons-Oosterhuis1, L. van Berkel1, S. Nugteren1, J. Arnold1, Y. Wakabayashi4, J. Zhu4, L. de Ridder3, G. Driessen5, J. Escher3, W. Leonard2, J. Samsom1

Created: Friday, 22 February 2019, 9:49 AM
DOP008: Dietary manipulation of the healthy human and colitic murine gut microbiome by CD-TREAT diet and exclusive enteral nutrition; a proof of concept study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Svolos V.1, Hansen R.2, Ijaz U.Z.3, Quince C.4, Watson D.5, Alghamdi A.5, Brejnrod A.4, Ansalone C.6, Milling S.6, Gaya D.7, Russell R.2, Gerasimidis K.*1

Created: Wednesday, 20 February 2019, 10:36 AM
DOP008: Human intestinal Vδ2+ T-cells acquire antigen-presenting potency upon exposure to microbial phosphoantigen: modulation by mucosal inflammation and vedolizumab therapy
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

C. Tyler1, N. McCarthy*2, B. Moser1, A. Stagg2, M. Eberl1, J. Lindsay2, 3

Created: Friday, 22 February 2019, 9:49 AM
DOP008: Safety of adalimumab in children and adolescents with moderate-to-severe Crohn’s disease: interim results of the CAPE registry
Year: 2018
Source: ECCO '18 Vienna
Authors:

D. Turner1*, S. Koletzko2, H. Winter3, R. Baldassano4, M. Dubinsky5, W. Faubion6, J. Hyams7, S. Kugathasan8, J. Rosh9, J. Escher10, A. Griffiths11, J. Kierkus12, R. Russell13, G. Heap14, D. Arikan14, V. Kuehnl15, J. Petersson14, A. Robinson16, F. Ruemmele17

Created: Thursday, 21 February 2019, 9:14 AM
DOP009: An autoimmunity-associated variant in PTPN22 protects from disease onset in mouse models of colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Spalinger*1, S. Kasper1, C. Gottier1, S. Lang1, M. Fried1, 2, G. Rogler1, 2, M. Scharl1, 2

Created: Friday, 22 February 2019, 9:49 AM
DOP009: Choice of corticosteroids or exclusive enteral nutrition as the first induction of remission therapy does not affect disease behavior within two years of diagnosis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Cohen-Dolev N.*1, Sladek M.2, Sigall Boneh R.1, Veres G.3, Hussey S.4, Staiano A.5, Nuti F.6, Lionetti P.7, Koletzko S.8, Levine A.1

Created: Wednesday, 20 February 2019, 10:36 AM
DOP009: Comparative safety profile of vedolizumab and tumour necrosis factor–antagonist therapy for inflammatory bowel disease: a multicentre consortium propensity score-matched analysis
Year: 2018
Source: ECCO '18 Vienna
Authors:

D. Lukin1, A. Weiss1, S. Aniwan2, S. Kadire3, G. Tran3, M. Rahal3, D. Faleck4, A. Winters4, S. Chablaney4, J. Meserve5, G. Kochhar6, P. Shashi6, J.L. Koliani-Pace7, M. Bohm3, S.V. Sagi3, M. Fischer3, B. Boland5, S. Singh5, R. Hirten4, E. Shmidt4, D. Hudesman8, S. Chang8, K. Sultan9, A. Swaminath10, N. Gupta11, S. Kane2, E.V. Loftus2, B. Shen6, B.E. Sands4, W.J. Sandborn5, J.-F. Colombel4, C.A. Siegel7, P.S. Dulai5*

Created: Thursday, 21 February 2019, 9:14 AM
DOP01 Exclusive enteral nutrition for the treatment of adult Crohn’s disease
Year: 2020
Source: ECCO'20 Vienna
Authors: D. Shukla, L. Purcell, M. Palmer, L. Pillay
Created: Thursday, 30 January 2020, 10:12 AM
Last Modified: Tuesday, 4 August 2020, 1:21 PM by Dauren Ramankulov
DOP010: Activating PIK3CD mutations cause severe intestinal lymphonodular hyperplasia and an IBD-like phenotype
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Farachi1, L. Werner2, L. Konnikova3, F. Rea1, I. Vardi4, E. Romeo1, O. Barel4, P. De Angelis1, L. Dall’Oglio1, G. Rechavi4, S. Snapper3, R. Somech2, B. Weiss5, C. Cancrini1, D. Shouval2*

Created: Thursday, 21 February 2019, 9:14 AM
DOP010: ECCO topical review on transitional care in inflammatory bowel disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

van Rheenen P. ECCO Transition Topical Review Consensus Group

Created: Wednesday, 20 February 2019, 10:36 AM
DOP010: Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from a Central European nationwide cohort
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. Bálint*1, K. Farkas1, M. Rutka1, Z. Végh2, Z. Kürti3, J. Banai4, L. Bene5, B. Gasztonyi6, T. Kristóf7, L. Lakatos8, P. Miheller9, K. Palatka10, A. Patai11, A. Salamon12, T. Szamosi4, Z. Szepes1, G.T. Tóth13, A. Vincze14, R. Bor1, A. Milassin1, F. Nagy1, M. Kolar15, 16, M. Bortlik15, 17, D. Duricova15, 18, V. Hruba15, M. Lukas15, K. Mitrova15, 19, K. Malickova20, M. Lukas15, 20, P.L. Lakatos2, T. Molnár1

Created: Friday, 22 February 2019, 9:49 AM
DOP011: Early immunomodulator exposure and the long-term outcome of Crohns disease: target for changing the natural history
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. Jeuring*1, 2, D. Wintjens1, A. Wesselius3, T. Van den Heuvel1, 2, 
M. Zeegers3, 4, W. Hameeteman1, M. Romberg-Camps5, L. Oostenbrug6, A. Masclee1, 2, D. Jonkers1, 2, M. Pierik1, 2

Created: Friday, 22 February 2019, 9:49 AM
DOP011: Genotype–phenotype association analysis of inflammatory bowel disease in 6395 East Asian subjects: results from the international IBD Genetics Consortium
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Abedian1*, S.H. Wong2, S. Van Sommeren3, A. Takahashi4, J.H. Cheon5, W.H. Kim5, K. Yamazaki6, S.-K. Yang7, M. Kubo6, R.K. Weersma3, B.Z. Alizadeh1, S.C. Ng2

Created: Thursday, 21 February 2019, 9:14 AM
DOP011: Risk of opportunistic infection in healthcare personnel with inflammatory bowel disease: a case-control study of the GETAID
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Gagniere C.*1, Bourrier A.2, Seksik P.2, Gornet J.-M.3, Dewit O.4, Nancey S.5, Altwegg R.6, Abitbol V.7, Laharie D.8, Reenaers C.9, Buisson A.10, Nachury M.11, Viennot S.12, Vuitton L.13, Stefanescu C.14, Marteau P.15, Bouguen G.16, Cosnes J.2, Amiot A.1

Created: Wednesday, 20 February 2019, 10:36 AM
DOP012: Disease demarcation in ulcerative colitis is associated with different patterns of gene expression
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Suarez-Farinas1, R. Huang1, R. Kosoy1, A. Irizar1, B. Losic1, G. Wei1, L. Peters1, W.-m. Song1, A. Di Narzo1, W. Wang1, J. Perrigoue2, A. Castillo3, J. Rogers3, A. Atreja3, A. Hurley1, M. Mahajan1, B. Zhang1, A. Stojmirovic2, M. Curran2, R. Dobrin2,4, M. Dubinsky3, K. Hao1, J. Zhu1, E. Schadt1, S. Plevy2, J. Friedman2, C. Brodmerkel2, B. Sands3, A. Kasarskis1, R. Ungaro3, C. Argmann1*, J.-F. Colombel3

Created: Thursday, 21 February 2019, 9:14 AM
DOP012: Do ulcerative colitis patients treated with corticosteroids at diagnosis really have a more aggressive disease course?
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

L. Bertani*1, N. de Bortoli1, G. Bodini2, G. Mumolo3, L. Ceccarelli4, M. C. Plaz Torres2, G. Laino1, M. Bellini3, A. Ricchiuti3, V. Savarino2, S. Marchi1, F. Costa3

Created: Friday, 22 February 2019, 9:49 AM
DOP012: Impact on clinical practice of Epstein-Barr virus infection in patients with inflammatory bowel disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

de Francisco R.*1, Riestra S.1, Pérez-Martínez I.1, Castaño A.1, Martínez-González S.1, Jiménez S.2, González A.J.3, Morais L.R.3, Suárez A.1

Created: Wednesday, 20 February 2019, 10:36 AM
DOP013: A 104 week mucosal healing assessment of symptomatic small bowel Crohns disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

B. Hall*1, G. Holleran1, L. Chapman1, B. Ryan1, N. Mahmud2, D. McNamara1

Created: Friday, 22 February 2019, 9:49 AM
DOP013: An IBD-associated variant in PTPN2 promotes inflammatory responses but enhances the anti-inflammatory effect of spermidine
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Butter*, N. Obialo, K. Bäbler, L. Van der Lely, S. Lang, C. Gottier, M. Scharl, M.R. Spalinger

Created: Thursday, 21 February 2019, 9:14 AM
DOP013: Definition of therapeutic response criteria using MRI in Crohn's disease patients treated with anti-TNF therapy: a multicenter prospective study (the IRMA study)
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Buisson A.*1,2, Messadeg L.3, Bouguen G.4, Goutorbe F.1,5, Reimund J.-M.6, Goutte M.1,2, Sautel C.7, Duron C.8, Scanzi J.1, Reymond M.1, Allimant C.1, Dapoigny M.1, Bommelaer G.1,2, Pereira B.9, Hordonneau C.3

Created: Wednesday, 20 February 2019, 10:36 AM